Gamma Secretase Inhibitor Improves Responses to BCMA CAR T Cells in Myeloma

SCCA’s Andrew Cowan, MD, provided commentary about a Phase 1 clinical trial evaluating the combination of a gamma-secretase inhibitor (GSI) therapy with BCMA CAR T cells to improve response in heavily pretreated patients that was presented at ASH 2019.

Read the Story Here